• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Granuloma (1876); Fibrosis (3167)
Event Date 04/01/2023
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that orise gel was used to lift a polyp during a resection procedure on an unknown date.The physician was unable to resect the lesion during the initial procedure and referred the patient for an endoscopic submucosal dissection (esd) procedure.About 3-4 months later, during the esd procedure, the polyp appeared firm and adherent to the muscle layer.As the physician had prior imaging from the index procedure, the polyp gave the impression of a more advanced tumor.The submucosal dissection was difficult to perform as there was little identifiable submucosa, but rather thick white slab of fibrosis-like material.The physician had to dissect around this area, taking more tissue than intended.The pathology showed foreign body reaction to orise gel.There are no further patient complications reported at this time.
 
Manufacturer Narrative
Block b3: the exact date of the event is unknown.The provided event date was chosen as a best estimate based on the date that the manufacturer became aware of the event.Block d4 and h4: the complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: impact code f23 captures the reportable event of unexpected medical intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORISE GEL
Type of Device
SUBMUCOSAL INJECTION AGENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC LIMITED
model farm road
cork
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16911979
MDR Text Key315011258
Report Number3005099803-2023-02393
Device Sequence Number1
Product Code PLL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date 05/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/17/2023
Initial Date FDA Received05/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Removal/Correction Number92970101-FA
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-